All News about Ascendis Pharma ADR![]()
The Latest Analyst Ratings for Ascendis Pharma
September 07, 2023
Via Benzinga
![]()
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 05, 2023
From Royalty Pharma plc
Via GlobeNewswire
![]() ![]()
Earnings Preview For Ascendis Pharma
September 04, 2023
Via Benzinga
![]()
Analyst Expectations for Ascendis Pharma's Future
July 24, 2023
Via Benzinga
![]() ![]()
Where Ascendis Pharma Stands With Analysts
June 20, 2023
Via Benzinga
![]() ![]() ![]()
The Latest Analyst Ratings for Ascendis Pharma
June 01, 2023
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Analyst Ratings for Ascendis Pharma
April 03, 2023
Via Benzinga
![]() ![]() Via NewMediaWire
Exposures
Product Safety
![]()
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|